Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]
Soosay Raj TA, Smith AM, Moore AS. Int J Nanomedicine. 2013;8:4361–4369.On page 4366, Table 1, Notes,Notes: Reproduced with permission of Wiley and Sons. Moore A, Pinkerton R. Vincristine: can its therapeutic index be enhanced? Pediatr Blood Cancer. 2009;53(7):1180–1187.22Should...
Guardado en:
Autores principales: | Soosay Raj TA, Smith AM, Moore AS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f2d91b0b4f174846b0097cd3954063d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia
por: Soosay Raj TA, et al.
Publicado: (2013) -
Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine
por: Davis T, et al.
Publicado: (2013) -
The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate
por: Zhang J, et al.
Publicado: (2016) -
Delivery of vincristine sulfate-conjugated gold nanoparticles using liposomes: a light-responsive nanocarrier with enhanced antitumor efficiency
por: Liu Y, et al.
Publicado: (2015) -
First-line treatment of acute lymphoblastic leukemia with pegasparaginase
por: Riccardo Masetti, et al.
Publicado: (2009)